BMRN
BioMarin Pharmaceutical Inc. · Healthcare
CEO Jean Jacques Bienaime sold $378K of BioMarin Pharmaceutical Inc.
Sold$377,600
$94.40Price
4,000Shares
−1%Stake
What BMRN did after the filing
Prices for BMRN after this filing aren't in yet.
Traded Fri, Mar 15. Filed Tue, Mar 19, 7:21 PM ET, after the close. Not investment advice.